U.K. regulators MHRA approved Wegovy for risk of major cardiovascular events

MHRA approved Wegovy for risk of major cardiovascular events

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wegovy (semaglutide) for a new purpose: to help reduce the risk of heart problems in people who are overweight or obese. Specifically, the drug has been approved for individuals with a body mass index (BMI) of 27 or over who have already been diagnosed Read more: U.K. regulators MHRA approved Wegovy for risk of major cardiovascular events..

GE Aerospace signs UK MoD Defence Aviation Net Zero Charter

GE Aerospace signs UK MoD Defence Aviation Net Zero Charter

GE Aerospace recently signed the UK Ministry of Defence’s (MoD) Defence Aviation Net Zero Charter. This commitment signifies their dedication to supporting the UK’s net-zero ambitions and working collaboratively with partners to reduce emissions in defense aviation operations. The charter was signed on July 19, 2024, at the Royal International Air Tattoo (RIAT) by Scott Read more: GE Aerospace signs UK MoD Defence Aviation Net Zero Charter..